U.S. Other Utilities Stock News

NYSE:STNG
NYSE:STNGOil and Gas

How Scorpio’s Low‑Coupon Convertibles, Buybacks, and Micronuclear Bet Have Changed Its Investment Story (STNG)

In early April 2026, Scorpio Tankers Inc. completed a US$375 million private offering of 1.75% convertible senior notes due 2031, using about US$100 million of the proceeds to repurchase approximately 1.34 million shares and also agreed to sell two 2015-built MR product tankers for US$35.0 million each, with closing expected in the second quarter of 2026. Alongside these financing and fleet moves, Scorpio Tankers entered a collaboration with AMPERA, Inc. to pursue micronuclear power...
NYSE:DOC
NYSE:DOCHealth Care REITs

A Look At Healthpeak Properties (DOC) Valuation After Dividend Confirmation And Ahead Of Q1 2026 Earnings

Healthpeak Properties (DOC) is back in focus after its board affirmed a monthly common stock cash dividend of $0.10167 per share for the second quarter of 2026, which is annualized at $1.22. See our latest analysis for Healthpeak Properties. At a share price of US$16.74, Healthpeak Properties has recently shown modest near term momentum, with a 7 day share price return of 1.33%. However, its 1 year total shareholder return of a 1.18% decline and 5 year total shareholder return of a 33.99%...
NYSE:UTI
NYSE:UTIConsumer Services

A Look At Universal Technical Institute’s Valuation After Earnings Beat And New Campus Expansion Plans

Why Universal Technical Institute (UTI) is back on investors’ radar Universal Technical Institute (UTI) recently posted a quarter where revenue and earnings came in ahead of forecasts, and also unveiled plans for several new campuses that will extend its transportation, skilled trades, and healthcare footprint. See our latest analysis for Universal Technical Institute. That growth story is showing up in the share price too, with the stock at $35.58 after a 29.38% 90 day share price return and...
NYSE:NJR
NYSE:NJRGas Utilities

Does NJR’s Earnings Beat and Utility Clean Energy Mix Shift Its Core Investment Story?

Earlier this month, New Jersey Resources reported fiscal 2026 first-quarter results that beat Wall Street expectations for both earnings per share and revenue, reflecting stronger performance across its utility and energy-related segments. The upside surprise in earnings has reinforced investor attention on how the company’s mix of natural gas distribution and clean energy initiatives is contributing to its current financial performance. Next, we’ll assess how this earnings beat and renewed...
NasdaqGS:DPZ
NasdaqGS:DPZHospitality

Can Domino's (DPZ) Shinola Tie-In Reveal How Far Its Brand Elevation Strategy Can Stretch?

Domino's Pizza Inc. recently launched Slice Sauce, its first dedicated pizza dipping sauce, and ran a promotion giving customers a free Slice Sauce with any online Handmade Pan or Parmesan Stuffed Crust Pizza purchase through June 14, while also providing password-only access to a curated Shinola collection featuring black-and-gold watches and leather goods at preferred rates. This collaboration links Domino's core menu innovation with a premium lifestyle brand, signaling an effort to...
NYSE:ECG
NYSE:ECGConstruction

Assessing Everus Construction Group (ECG) Valuation After Strong Recent Share Price Momentum

Why Everus Construction Group (ECG) is on investors’ radar Everus Construction Group (ECG) has drawn fresh attention after a period of strong recent share performance, with the stock showing positive returns over the past week, month, past 3 months and year. For investors watching capital goods names, the company’s US focused contracting business, spanning Electrical & Mechanical and Transmission & Distribution services, offers a mix of infrastructure exposure and earnings tied to utilities,...
NasdaqGS:OPEN
NasdaqGS:OPENReal Estate

Opendoor Technologies (OPEN) Is Down 8.9% After Weak Housing Data Tests Its Interest‑Rate‑Sensitive Model

In recent days, Opendoor Technologies has been in focus as fresh economic and housing data pointed to weaker consumer conditions, slowing growth, rising inflation, and the sharpest drop in U.S. pending home sales in three months, while mortgage rates climbed to their highest level since September. These macro pressures, combined with concerns about Opendoor’s inventory-heavy, interest-rate‑sensitive model and mixed options and retail sentiment signals, have intensified questions about the...
NYSE:MKL
NYSE:MKLInsurance

Does Markel Group’s Governance Stance Signal a Deeper Shift in Shareholder Alignment for MKL?

In early April 2026, Markel Group Inc. disclosed that its upcoming May 20, 2026 annual meeting would consider amendments to its Articles of Incorporation alongside shareholder proposals seeking the right for 10% owners to call special meetings and a report on plans to mitigate material environmental risks. The company’s decision to recommend voting against both the special-meeting and environmental-risk reporting proposals highlights a clear tension between management’s preferred governance...
NasdaqCM:ASTH
NasdaqCM:ASTHHealthcare

Is Astrana Health’s (ASTH) New Universal Shelf Quietly Rewriting Its Capital Flexibility Narrative?

In March 2026, Astrana Health, Inc. filed shelf registrations, including an ESOP-related shelf of up to US$120.95 million for 5,000,000 common shares, alongside a broad universal shelf covering common and preferred stock, debt securities, depositary shares, warrants, purchase contracts, units, and subscription rights. This broad financing toolkit, including employee stock ownership plan capacity and multiple capital instruments, gives Astrana additional flexibility to support future...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

How Fox (FOXA) Valuation Stacks Up After Kalshi Prediction Market Partnership

Fox (FOXA) is in focus after announcing an integration with prediction market Kalshi. The deal will bring real-time, crowd-sourced odds into FOX News, FOX Business Network, FOX Weather, and FOX One programming. See our latest analysis for Fox. Despite an initial jump on the Kalshi news, the 1-day share price return of 2.77% decline sits against a 7-day share price return of 4.09% and a 90-day share price return of 17.18% decline. Total shareholder returns of 26% over 1 year and 89.69% over 3...
NYSE:ROL
NYSE:ROLCommercial Services

Rollins (ROL) Valuation Check After Earnings Miss And Ongoing Growth Investments

Why Rollins (ROL) is back in focus after its latest quarterly update Rollins (ROL) has moved back onto investors’ watchlists after reporting quarterly results where revenue was higher year on year, but adjusted operating income fell short of market expectations. See our latest analysis for Rollins. The earnings miss appears to have weighed on sentiment, with a 1 day share price return showing a 2.8% decline at US$54.23 and a 90 day share price return showing a 10.63% decline. However, the 5...
NYSE:EVTL
NYSE:EVTLAerospace & Defense

Did Vertical’s US$775 Million Structured Financing and Test Flight Milestone Just Shift EVTL’s Investment Narrative?

Vertical Aerospace announced in March 2026 that it had reached an agreement in principle for up to US$775,000,000 in new financing, including senior secured convertible notes, Series A convertible preferred shares and an equity line of credit with Mudrick Capital Management and Yorkville Advisors. This combination of sizeable, structured funding and the recent first piloted transition flight of its full-scale eVTOL aircraft under U.K. CAA oversight marks a meaningful step in aligning...
NYSE:MNSO
NYSE:MNSOMultiline Retail

A Look At MINISO Group Holding’s Valuation As Earnings Dividend And Buyback Update Land

MINISO Group Holding (MNSO) has released a packed update, combining fourth quarter and full year 2025 earnings with fresh dividend details and progress on its multi quarter share buyback program. See our latest analysis for MINISO Group Holding. Despite the fresh dividend announcements and the update on its multi quarter buyback, MINISO Group Holding's 1 day share price return of 3.06% decline and 90 day share price return of 20.10% decline contrast with a 1 year total shareholder return of...
NYSE:WM
NYSE:WMCommercial Services

What Waste Management (WM)'s Earnings, Buybacks and Dividend Track Record Means For Shareholders

In recent days, attention on Waste Management has intensified ahead of its April 28, 2026 earnings release, as analysts highlight expectations for higher quarterly and full‑year profit and revenue alongside the company’s ongoing share repurchase program and decades-long pattern of dividend increases. This combination of anticipated profit growth, sustained capital returns, and growing interest in recycling and renewable natural gas has become a key focus for investors reassessing Waste...
NYSE:VRT
NYSE:VRTElectrical

Vertiv Holdings Co (VRT) Is Up 12.9% After $50 Million Ohio AI Cooling Expansion - Has The Bull Case Changed?

Vertiv Holdings Co recently committed about US$50 million to expand its Ironton manufacturing plant and Westerville headquarters in Ohio, aiming to boost liquid cooling and chilled water system capacity for AI and high-density computing while adding hundreds of jobs through 2029. This expansion underpins Vertiv’s broader role as a critical provider of power and thermal infrastructure for AI data centers, reinforcing its ability to meet rising demand with shorter supply chains and greater...
NYSE:IBM
NYSE:IBMIT

Is IBM’s (IBM) Open AI Push Quietly Redefining Its Core Enterprise Infrastructure Story?

In early April 2026, Anthropic, Genentech, IBM, Meta, Microsoft, and others launched the Shared AI License Foundation and IBM expanded its AI, quantum, and hardware collaborations, while also securing FedRAMP authorization for 11 watsonx and automation tools and settling a US$17,000,000 U.S. DEI probe. Together, these moves underline IBM’s push to position itself at the center of open, enterprise-grade AI and quantum infrastructure while addressing regulatory scrutiny. We’ll now explore how...
NasdaqGM:ARRY
NasdaqGM:ARRYElectrical

Array Board Overhaul And End Of Staggered Terms Might Change The Case For Investing In Array (ARRY)

Array Technologies, Inc. recently disclosed that seven independent directors, including long-serving members and newer renewable-energy specialists, will not stand for re-election at the May 19, 2026 annual meeting, while also proposing to phase out its classified board structure in favor of annual director elections by 2029. This combination of significant board turnover and a move toward annual elections signals a shift in corporate governance that may recalibrate how investors assess...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Should Amneal’s New Generic Glaucoma Launch Shape How AMRX Investors View Its Specialty Strategy?

On 9 April 2026, Amneal Pharmaceuticals announced it had launched bimatoprost ophthalmic solution 0.01% in multiple vial sizes, a generic equivalent to Allergan’s LUMIGAN indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. This launch adds a high-usage ophthalmic therapy with approximately US$719 million in recent U.S. annual sales to Amneal’s generics portfolio, underlining its focus on expanding access to lower-cost treatments...
NYSE:MHK
NYSE:MHKConsumer Durables

Is Mohawk Industries’ (MHK) Supermajority Stance Clouding the Signal From Its Restructuring Story?

In early April 2026, Mohawk Industries filed a definitive proxy statement urging shareholders to vote against John Chevedden’s proposal to replace supermajority voting thresholds with a simple majority standard in its charter and bylaws. This clash over corporate governance comes as Mohawk is already in the spotlight for mixed quarterly results, efficiency initiatives, and active capital returns. We’ll now examine how this governance dispute, alongside Mohawk’s recent restructuring...
NYSE:ES
NYSE:ESElectric Utilities

A Look At Eversource Energy’s (ES) Valuation As FERC’s ROE Cut Reshapes 2026 Earnings Outlook

The Federal Energy Regulatory Commission’s decision to lower allowed returns for New England transmission owners is set to trim Eversource Energy (ES) 2026 after-tax earnings, prompting updated guidance and raising fresh questions for income-focused investors. See our latest analysis for Eversource Energy. At a share price of US$69.97, Eversource’s recent 5.4% 1 month share price decline contrasts with a 3.2% 3 month share price gain and a 30.0% 1 year total shareholder return. This suggests...
NYSE:CNS
NYSE:CNSCapital Markets

Cohen & Steers’ AUM Drop Despite Inflows Might Change The Case For Investing In CNS

Cohen & Steers recently reported preliminary assets under management of US$93.10 billion as of March 31 2026, down from US$98.40 billion a month earlier, with the decline mainly linked to market depreciation and client distributions, partly offset by net inflows. This shift in assets under management highlights how market conditions and payout decisions can affect fee-earning assets even when new client money is coming in. We’ll now explore how this recent assets-under-management decline may...
NYSE:H
NYSE:HHospitality

Is Hyatt (H) Quietly Redefining Its Investment Story Through Brand Diversification And New Partnerships?

In recent weeks, Brigade Group subsidiaries BCV Developers and Brigade Hotel Ventures announced new management agreements with Hyatt for Hyatt House Bengaluru Devanahalli, slated to open in 2027, and Grand Hyatt Chennai ECR, targeted for 2029, while Hyatt Regency Niagara Falls Fallsview joined the World of Hyatt portfolio and Caption by Hyatt Chattanooga Downtown opened as the brand’s first property in the city. Taken together, these openings and signings highlight Hyatt’s push into...
NasdaqGS:ROIV
NasdaqGS:ROIVBiotechs

Is Brepocitinib’s LPP Trial And Mixed Batoclimab Data Altering The Investment Case For Roivant Sciences (ROIV)?

Roivant Sciences recently reported that Priovant has begun enrolling patients in a seamless Phase 2b/3 trial of brepocitinib for lichen planopilaris and released past topline Phase 3 data from Immunovant’s batoclimab thyroid eye disease studies, which did not meet their primary endpoint but showed consistent safety. The update underscores Roivant’s growing late-stage immunology pipeline, led by brepocitinib’s FDA Priority Review in dermatomyositis and multiple additional indications...
NasdaqGM:URGN
NasdaqGM:URGNBiotechs

UroGen Pharma (URGN) Is Up 14.6% After Phase 3 ENVISION Data And LG-UTUC Outreach Push

In late March and early April 2026, UroGen Pharma announced publication of pivotal Phase 3 ENVISION data for bladder cancer therapy ZUSDURI and launched its “LG-UTUC Luminaries” program to recognize leaders in kidney-sparing care for rare upper tract urothelial cancer. Together, these steps highlight UroGen’s push to embed ZUSDURI’s evidence into clinical practice while deepening relationships with urologists focused on organ-preserving cancer management. Next, we’ll examine how the ENVISION...